A model for the function of glycosaminoglycans in the urinary tract.
Investigations into the antibacterial defense mechanisms of the urinary tract revealed an important function for cell surface glycosaminoglycans (GAG), that of a generalized antiadherent activity. This activity was found to prevent bacterial, protein, and ionic adherence to the cell membrane. A model was developed to explain mechanically the activity of sulfated polysaccharides at the bladder surface. The model predicted injurious effects of quaternary amines and also that the mucus would be the so-called blood-urine barrier. It also led to the hypothesis that exogenous polysaccharides may be important in treating bladder disease such as infection and interstitial cystitis. For the first clinical test of these concepts, a polysaccharide was employed in several double-blind studies and was shown to ameliorate significantly the symptoms of interstitial cystitis. These discoveries suggest new methods to manipulate the microenvironment between the transitional cell surface and the urine, leading to novel therapies in regulating disease of the genitourinary tract. They also stress the importance of understanding the mechanisms by which GAGs exert their effect in the urinary tract and how they are produced, maintained, and even inactivated (e.g., by urinary substances such as protamine).
Parsons
C L
CL
Division of Urology, UCSD Medical Center.
D000818:Animals; D003556:Cystitis / Q000209:etiology; D006025:Glycosaminoglycans / Q000502:physiology*; D006801:Humans; D008954:Models, Biological; D009093:Mucus / Q000737:chemistry / Q000502:physiology; D001745:Urinary Bladder Diseases / Q000382:microbiology / Q000517:prevention & control; D014551:Urinary Tract / Q000737:chemistry; D014553:Urinary Tract Physiological Phenomena; D014556:Urine
D006025:Glycosaminoglycans